Zanamivir
RxNorm 69722
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 69722 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Zanamivir.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
FNPrescribable
Full form of descriptor (FN):
Product containing zanamivir (medicinal product)
(Atom ID: 9731734)
INPrescribable
Ingredient (IN):
Zanamivir
(Atom ID: 12253416)
PTPrescribable
Designated preferred name (PT):
Zanamivir
(Atom ID: 609460)
FNPrescribable
Full form of descriptor (FN):
Zanamivir (substance)
(Atom ID: 609468)
PTPrescribable
Designated preferred name (PT):
Zanamivir-containing product
(Atom ID: 10822779)
Patient Education
Zanamivir Oral Inhalation
Zanamivir is used in adults and children at least 7 years of age to treat some types of influenza ('flu') in people who have had symptoms of the flu for less than 2 days. This medication is also used to prevent some types of flu in adults and children at least 5 years of age when they have spent time with someone who has the flu or when there is a flu outbreak. Zanamivir is in a class of medications called neuraminidase inhibitors. It works by stopping the growth and spread of the flu virus in your body. Zanamivir helps shorten the time you have flu symptoms such as nasal congestion, sore throat, cough, muscle aches, tiredness, weakness, headache, fever, and chills.
[Learn More]
* Please review the disclaimer below.